Literature DB >> 19685526

Percutaneous computed tomography-guided lung biopsy and pleural dissemination: an assessment by intraoperative pleural lavage cytology.

Yoshifumi Sano1, Hiroshi Date, Shinichi Toyooka, Takahiro Oto, Masaomi Yamane, Takao Hiraki, Hideo Gobara, Hidefumi Mimura, Susumu Kanazawa.   

Abstract

BACKGROUND: Percutaneous computed tomography (CT)-guided needle biopsy remains one of the most important diagnostic tools in the management of lung nodules; however, it carries a risk of intrapleural dissemination of cancer cells.
METHODS: CT-guided lung biopsy was performed before surgery in 171 (34.8%) of 491 patients. A coaxial biopsy system was used that comprised a 19-gauge introducer needle and a 20-gauge core biopsy needle. A total of 412 (83.9%) of the 491 patients underwent intraoperative pleural lavage cytology just after thoracotomy. Intraoperative pleural lavage cytology was performed immediately after opening the thorax, after the pleural cavity was gently washed with 50 mL of saline.
RESULTS: No patients had implantation of cancer cells in the chest wall after a median follow-up of 20.2 months. Intraoperative pleural lavage cytology results were positive for 5 (2.9%) of the 171 patients who underwent CT-guided biopsy before surgery, in contrast to 13 (5.4%) of the 241 patients who did not undergo biopsy before surgery. The difference between the biopsy and nonbiopsy groups was not statistically significant. When the analysis was limited to patients with stage IA disease, intraoperative pleural lavage cytology results were positive for 1 (0.8%) of the 128 patients who underwent CT-guided biopsy, in contrast to 3 (2.7%) of the 110 patients who did not undergo biopsy. This difference was also not statistically significant.
CONCLUSIONS: No significant association was observed between percutaneous CT-guided lung biopsy and intraoperative pleural lavage cytology results, even in patients with stage IA disease. Percutaneous CT-guided lung biopsy with a coaxial needle does not seem to cause pleural dissemination. (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19685526     DOI: 10.1002/cncr.24620

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.

Authors:  Song Gao; Seth Stein; Elena N Petre; Waleed Shady; Jeremy C Durack; Carole Ridge; Prasad Adusumilli; Natasha Rekhtman; Stephen B Solomon; Etay Ziv
Journal:  Cardiovasc Intervent Radiol       Date:  2017-08-02       Impact factor: 2.740

2.  Risks of Transthoracic Needle Biopsy: How High?

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Michael K Gould
Journal:  Clin Pulm Med       Date:  2013-01-01

3.  Intraoperative fine-needle aspiration biopsy (FNA) for lung cancer: diagnostic value and risk of pleural dissemination.

Authors:  Takahisa Matsuoka; Makoto Sonobe; Hiroshi Date
Journal:  Surg Today       Date:  2014-09-16       Impact factor: 2.549

Review 4.  Computed Tomography-guided Lung Biopsy: A Review of Techniques for Reducing the Incidence of Complications.

Authors:  Kazuhiko Nakamura; Kensuke Matsumoto; Chie Inoue; Eiji Matsusue; Shinya Fujii
Journal:  Interv Radiol (Higashimatsuyama)       Date:  2021-11-01

5.  Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study.

Authors:  Chengping Hu; Juan Jiang; Yuanyuan Li; Chunfang Zhang; Weixing Zhang; Haihe Jiang; Yang Gao; Wei Zhuang; Kaibo Lei; Yong Tang; Rongjun Wan
Journal:  Cancer Manag Res       Date:  2018-07-06       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.